UT MD Anderson Presentations at ASTRO

ARRO 01 – ARRO Brachytherapy – Didactic session (Part I)

8–9 a.m. | Room 160

Optimizing precision with MARS LDR brachytherapy for prostate cancer treatment in the monotherapy, combined and salvage settings
8:45–9 a.m.
Presenter: Steven Frank, M.D.

Workshop 01 – Physics insights for advanced clinical practice: Adaptive, re-irradiation, AI and trials

8 a.m.–5:30 p.m. | Room 204

Opening Keynote: The physics advances in modern radiotherapy
8:05–9:05 a.m.
Presenter: David Jaffray, Ph.D.

Session 1 – Re-irradiation: Data driven decision-making: Imaging/dose escalation in trials
10:35–11:05 a.m.
Presenter: Kristy Brock, Ph.D.

Workshop 03 – Brachytherapy didactic session – General attendees (Part I)

10–11 a.m. | Room 160

Optimizing precision with MARS LDR brachytherapy for prostate cancer treatment in the monotherapy, combined, and salvage settings
10:45–11 a.m.
Presenter: Steven Frank, M.D.

ARRO 04 – ASTRO-ARRO Medical student workshop

12–4 p.m. | Room 153

Shaping your path: Academic and extracurricular excellence in radonc panel
12:10–12:20 p.m.
Presenter: Rehema Thomas, M.D.

Workshop 05 – ACGME workshop: Review committee update and accreditation info you need for your program

1–2:30 p.m. | Room 254

RO review committee information and RC program requirement changes and initiatives
1–1:45 p.m.
Presenter: Prajnan Das, M.D.

Workshop 07 – When disaster strikes: Safeguarding radiotherapy's value and continuity across catastrophic events

2:30–4 p.m. | Room 257

Moderator: Fumiko Chino, M.D.

QP 02 – Advances in pediatric radiotherapy and side effect mitigation

3–4 p.m. | Room 256

Abstract 1007 – Radiation oncology workflow-integrated coronary artery disease risk calculator for pediatric and adolescent cancer patients
3:10–3:15 p.m.
Presenter: Rebecca Howell, Ph.D.

Abstract 1008 – Delays in adjuvant therapy initiation for Wilms tumor: Institutional patterns and clinical impact on disease control
3:15–3:20 p.m.
Presenter: Troy Kleber, M.D.

SS 02 – Escalate, de-escalate or substitute? Trials shaping prostate cancer care

3–4 p.m. | Room 205

Moderator: Seungtaek Choi, M.D.

SS 03 – Technologically driven strategies in HPV related OPSCC

3–4 p.m. | Room 162

Abstract 113 – MR-ADAPTOR: Randomized Phase 2 trial of weekly MRI-guided volumetric adaptation and elective neck deintensification for low-risk HPV-associated OPSCC
3:30–3:40 p.m.
Presenter: Warren Floyd, M.D., Ph.D.

SS 05 - Advances in radiation response and microenvironment

3–4 p.m. | Room 204

Abstract 123 – Clonal hematopoiesis following radiation therapy as a novel predictor of cancer control and survival: Analyses from prospective trials
3:20–3:30 p.m.
Presenter: Kevin Nead, M.D.

SS 09 – From trials to real-world impact

5–6 p.m. | Room 109

Moderator: Kevin Nead, M.D.

SS 11 – Interventions to advance healthcare access in radiation oncology

8–9 a.m. | Room 107

Abstract 153 – Alternative cancer treatment clinics in North America: Evidence gaps, regulatory concerns and financial burden
8:40–8:50 a.m.
Presenter: Zakaria El Kouzi, M.D.

SS 22 – Some crHEME with your coffee? A winning blend of radiation and systemic therapy in hematologic malignancies

10:45 a.m.–12 p.m. | Room 259

Moderator: Susan Wu, M.D.

SS 23 – Emerging pathways and targeted therapies

3–4 p.m. | Room 153

Moderator: Ann Klopp, M.D., Ph.D.

QP 08 – CNS metastases and LMD: Patient selection, treatment strategy and outcomes

3–4 p.m. | Room 254

Abstract 1047 – Predicting survival and treatment completion of proton craniospinal irradiation in leptomeningeal disease: A prognostic nomogram
3:30–3:35 p.m.
Presenter: Tejaswi Kanala, M.D., M.B.B.S.

QP 20 – Beyond treatment: Innovations in supportive care across the radiation oncology continuum

12:30–1:30 p.m. | Room 109

Moderator: Molly Tate, Ph.D.

Question and answers
1:05–1:25 p.m.
Presenter: Molly Tate, Ph.D.

Workshop 08 – Grant writing workshop

2:15–4:15 p.m. | Room 153

Moderator: Debra Yeboa, M.D.

Introductions, NIH review criteria
2:15–2:30 p.m.
Presenter: Debra Yeboa, M.D.

Specific aims
2:30–2:45 p.m.
Presenter: Kristy Brock, Ph.D.

PQA 01 – PQA 01: Gastrointestinal cancer and central nervous system

3–4 p.m. | Poster Hall – Exhibit Hall A

Abstract 2134 – Comparative analysis of the impact of proton vs. photon-based chemoradiation in esophageal cancer patients on peripheral blood lymphocyte profile and clonal diversity using single cell combinational sequencing
Presenter: Steven Lin, Ph.D.

Abstract 2041 – Risk factors for treatment-related effects in brainstem metastases following stereotactic radiosurgery
Presenter: Darien Colson-Fearon, M.D.

Abstract 2039 – Association of serum metabolomic signatures with survival in pancreatic cancer patients undergoing neoadjuvant therapy
Presenter: Diya Choudhary

Abstract 2114 – Fifteen-year longitudinal analysis of spine stereotactic radiosurgery for metastatic thyroid cancer
Presenter: Ryan Ko, M.D.

PQA 02 – PQA 02: Pediatric cancer, sarcoma and cutaneous tumors, medical education & professional development and health services research

4–5 p.m. | Poster Hall – Exhibit Hall A

Abstract 2321 – SATURN-STS: Phase 2 study of neoadjuvant atezolizumab with doxorubicin, concurrent atezolizumab with preoperative radiotherapy and adjuvant atezolizumab in patients with high-risk surgically resectable extremity and truncal soft tissue sarcoma
Presenter: Ahsan Farooqi, M.D., Ph.D.

Abstract 2309 – Evaluating the effect of tumor-draining nodal irradiation by flash vs. conventional dose-rate radiotherapy of a clinically relevant melanoma mouse model
Presenter: Patrick Carriere, M.D., Ph.D.

Abstract 2354 – Long-term outcomes for localized leiomyosarcoma of the extremity and superficial trunk treated with surgery and radiation therapy
Presenter: Jordan McDonald, M.D.

Abstract 2326 – Radiation pneumonitis after contemporary whole lung irradiation in pediatric sarcomas and Wilms tumor
Presenter: Ory Haisraely, M.D.

Abstract 2337 – Outcomes following combined modality local therapy vs. surgery alone for patients with non-metastatic intrathoracic soft tissue sarcomas 
Presenter: Tejaswi Kanala, M.D., M.B.B.S.

Abstract 2323 – Proton vs. photon radiotherapy for patients with oropharyngeal cancer in the USA: A cost-effectiveness analysis
Presenter: Steven Frank, M.D.

PQA 03 – PQA 03: Digital health innovation and informatics, patient safety & quality and radiation and cancer biology

10:45 a.m.–12 p.m. | Poster Hall – Exhibit Hall A

Abstract 2616 – Natural killer cells inhibit radiation induced anti-tumor immune responses
Presenter: Michael Spiotto, M.D., Ph.D.

Abstract 2565 – Harnessing the immune temperature to predict and personalize radiotherapy
Presenter: Awino Maureiq Ojwang, Ph.D.

Abstract 2469 – Incorporation of variable RBE in radiation-induced lymphopenia prediction risk modeling for proton therapy
Presenter: Madison Grayson

Abstract 2454 – Multidisciplinary rapid access bone metastasis clinic: Expeditious workflow from referral to palliative radiotherapy
Presenter: Ahmed Fetooh, M.D.

Abstract 2606 – Machine learning-based prognostic clinical-genomic model of disease recurrence after chemoradiation and durvalumab in unresectable stage II-III NSCLC
Presenter: Kayeong Shin, M.D.

Abstract 2537 – Targeting radiation-triggered cell-surface GRP78 via antibody-drug conjugate for gastric cancer 
Presenter: P.M. Quan Mai

Abstract 2551 – Carbon ion radiotherapy synergizes with KRASG12D inhibition to overcome acquired resistance in pancreatic cancer
Presenter: Henry Meyer

Abstract 2641 – Single-dose FLASH vs. conventional-dose-rate proton effect on immune modulation in murine prostate cancer models
Presenter: Li Wang, M.D., Ph.D.

Abstract 2614 – LLM-driven extraction of NI-RADS and imaging tumor characteristics to enhance oropharyngeal cancer survivorship surveillance
Presenter: Wenye Song, M.D., Ph.D.

Abstract 2669 – Testing adaptive radiation fractionation in head and neck cancer using digital twins of clinical trials
Presenter: Mohammad Zahid, Ph.D.

PQA 04 – PQA 04: Breast cancer, patient reported outcomes/qol/survivorship, functional radiation medicine, hematologic malignancies, palliative care and international/global oncology

3–4 p.m. | Poster Hall – Exhibit Hall A

Abstract 2797 – An analysis of acute-on-chronic pain and opioid dependency in a prospective head and neck cancer cohort treated with radiation therapy
Presenter: Md Mahin, Ph.D.

Abstract 2823 – Long-term skin-related quality of life in patients receiving post-operative radiation therapy for cutaneous melanoma
Presenter: Kelsey Nordlund

Abstract 2836 – Shortening adjuvant photon and proton irradiation (SAPPHIRe-II) prospective clinical trial
Presenter: Jane Pearce, M.D.

Abstract 2778 – Radiation therapy for breast cancer: Impact of DNA repair gene mutations on oncologic outcomes
Presenter: Forrest Kwong, M.D.

Abstract 2688 – Identifying risk factors for an AI model to predict skin toxicity in breast radiation
Presenter: Raleigh Anderson, M.D.

Abstract 2774 – Local control in metastatic breast cancer: Outcomes of hypofractionated radiotherapy and SBRT for locoregional oligoprogression during systemic therapy
Presenter: Esengul Kocak, M.D.

Abstract 2857 – Skin-related quality of life during radiotherapy across diverse Fitzpatrick skin types and its association with radiation dermatitis
Presenter: Aya Salem, M.D.

Abstract 2815 – Response-directed radiotherapy after methotrexate-based systemic therapy for patients with primary CNS lymphoma
Presenter: Ansel Nalin, M.D., Ph.D.

Abstract 2835 – Disease control following radiotherapy for limited-site relapse of follicular lymphoma
Presenter: Pranalee Patel, M.D.

Abstract 2921 – Phase 2 study of low dose bridging radiotherapy prior to axicabtagene-ciloleucel in patients with relapsed/refractory follicular lymphoma
Presenter: Susan Wu, M.D.

Abstract 2897 – Prospective evaluation of acute cutaneous toxicity during proton vs. photon radiotherapy for patients with head and neck cancer and varied baseline skin pigmentation
Presenter: Rehema Thomas, M.D.

PQA 05 – PQA 05: Physics

12:30–1:45 p.m. | Poster Hall – Exhibit Hall A

Abstract 3014 – Machine learning-based prediction of regional liver volume response after radiotherapy in patients with liver malignancies
Presenter: Aashish Gupta

Abstract 3080 – Considerations of plan adaptation and CBCT-based accumulated dose in the prediction of patient-reported xerostomia post radiotherapy for oropharyngeal cancer patients
Presenter: Androniki Mitrou

Abstract 3177 – Imaging biomarkers for early detection, monitoring and prediction of radiotherapy-related side effects: A scoping review
Presenter: Natalie West

Abstract 3148 – Dosimetric impact of intra-delivery motion in stereotactic body radiotherapy to the prostate and dominant lesion
Presenter: Ka Ho Tam, Ph.D.

Abstract 2988 – A data-driven quality assurance for auto-segmentation model updates using a localized anisotropic margin metric
Presenter: Jingwei Duan, Ph.D.

PQA 06 – PQA 06: Genitourinary cancer, gynecological cancer and health care access and engagement

2:15–3:30 p.m. | Poster Hall – Exhibit Hall A

Abstract 3374 – Impact of short-term ADT on survival in unfavorable intermediate-risk prostate cancer treated with proton-beam radiotherapy: A retrospective cohort study
Presenter: Kayeong Shin, M.D.

Abstract 3375 – Pelvic radiotherapy increases severe lymphopenia in prostate cancer
Presenter: Kayeong Shin, M.D.

Abstract 3262 – Clinical outcomes of rectal wall infiltration following hydrogel spacer placement: A single-institution retrospective study
Presenter: Zakaria El Kouzi, M.D.

Abstract 3274 – Skeletal-related events after radiotherapy for non-spine bone metastases in renal cell carcinoma
Presenter: Harshath Gupta, M.D.

Abstract 3238 – Safety and clinical outcomes of combining radiotherapy with lutetium-177-PSMA therapy in metastatic castrate-resistant prostate cancer
Presenter: Patrick Carriere, M.D., Ph.D.

Abstract 3735 – MCT inhibition targets cervical cancer in lactate enriched microenvironments
Presenter: David Lo

Abstract 3741 – Molecular subtypes in patients with recurrent endometrial cancer treated with definitive radiation
Presenter: Lauren Bendesky, M.D.

PQA 07 – PQA 07: Head and neck cancer, lung cancer/thoracic malignancies and nursing and supportive care

3:45–5 p.m. | Poster Hall – Exhibit Hall A

Abstract 522 – A randomized study of head and neck radiotherapy with or without customized 3D printed oral stents
Presenter: Anna Lee, M.D.

Abstract 3564 – Beyond overlap metrics: Uncertainty-based triage for pathology-anchored QA of nodal autosegmentation in HPV-positive oropharyngeal cancer
Presenter: Yehia Mohamed, M.D.

Abstract 3622 – Safety and efficacy of proton beam therapy vs. IMRT for postoperative radiotherapy in non-small cell lung cancer: A systematic review and meta-analysis 
Presenter: Kayeong Shin, M.D.

Abstract 3547 – Pulsed targeted consolidative radiotherapy for patients with polymetastatic NSCLC
Presenter: Jennifer Livschitz, M.D.

Abstract 3447 – Systemic immune activation by mRNA vaccination synergizes with immune checkpoint inhibition and radiotherapy: A single-institution analysis
Presenter: Sage Copling

Abstract 3468 – Serial MRI-informed proliferation-saturation index modeling for risk-adapted radiotherapy in HPV-positive oropharyngeal cancer
Presenter: Lois Okereke